SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-041540
Filing Date
2021-02-12
Accepted
2021-02-12 16:16:05
Documents
3
Period of Report
2021-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d123441d8k.htm 8-K 19703
2 EX-99.1 d123441dex991.htm EX-99.1 6310
3 GRAPHIC g123441image001.jpg GRAPHIC 3638
  Complete submission text file 0001193125-21-041540.txt   32399
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 21627582
SIC: 2836 Biological Products, (No Diagnostic Substances)